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Abstract
Aquaporins (AQPs) are water channels that facilitate a rapid transport of water, across 
cell membranes. in some cases, these pores are also permeated by small solutes, par-
ticularly glycerol. Thirteen aquaporins (AQP0-12) have been identified so far in mam-
malian tissues. The disruption of the genes encoding aquaporins in transgenic mice 
has revealed their implication in physiological and pathophysiological processes, in-
cluding renal water absorption, neural function, digestion, tumour angiogenesis, and 
reproduction. A subset of aquaporins that transport both water and glycerol, the ‘aqua-
glyceroporins’, regulate glycerol content in epidermal, fat and other tissues, and are 
involved in skin hydration, fat metabolism and gluconeogenesis. Better understanding 
of the exact mechanisms and regulation of aquaporins might be useful for designing 
potential drug targets against different metabolic disorders, such as stroke, glaucoma, 
brain ooedema, cancer, diabetes and obesity.
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introduction
Aquaporins are channel-forming in-
tegral membrane proteins that allow 
the movement of water through cell 
membranes (1). The secondary struc-
ture proposed for aquaporins pre-
dicted six bilayer-spanning domains 
and two asparagine-proline-alanine 
motifs (NPA boxes) that confer selec-
tivity for water and/or other solutes 
(2) (Fig. 1). The three-dimensional 
structure of aquaporin resembles an 
hourglass; within the lipid belayed aq-
uaporins usually form tetramers, with 
each monomer defining a single pore. 
To date, 13 members of the family 
of aquaporins (AQP0-12) have been 
identified in different mammalian tis-
sues. According to their permeability 
characteristics, aquaporins can be di-
vided into two subgroups: aquaporins 
(pure water channels) and aquaglyc-
eroporins (channels permeated by wa-
ter and small solutes, such as glycerol, 
urea or nitric oxide [NO]) (3). Since 
their discovery in the early 1990s (4), 
the functional importance of plasma 
membrane water channels in mam-
malian tissues has been extensively 
studied by analysing the phenotype of 
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Table 1. Phenotype of aquaporin defi ciency in mice and humans AQP, aquaporin.
Aquaporin Aqp-knockout mice AQP-defi cient humans
AQP0 Cataracts (49) Congenital cataracts (50)
AQP1 Polydipsia, defective proximal fl uid reabsorption, 
impaired angiogenesis and vasodilation (55; 56; 
60)
Loss of Colton blood group, decreased urine-concentrating 
mechanism after water deprivation (54; 60)
AQP2 Severe urinary concentrating defect (105) Nephrogenic diabetes insipidus (65)
AQP3 Defective skin hydration, nephrogenic diabetes 
insipidus (15; 18; 19)
Antibodies against GIL blood group (14)
AQP4 Reduced brain swelling and improved outcome 
in models of brain oedema, mild urine-
concentrating defect (106-108)
Not described
AQP5 Impaired saliva and sweat secretion, 
hiperresponsive bronchoconstriction (72; 77; 109)
Not described
AQP6 Not described Not described
AQP7 Adult-onset obesity, increased insulin production 
and insulin resistance (29-31; 35)
Impaired increase of serum glycerol during exercise (36)
AQP8 Larger testes (87) Not described
AQP9 Defective glycerol metabolism (110) Not described
AQP10 Murine Aqp10 gene is a pseudogene (46) Not described
AQP11 vacuolisation and cyst formation of the proximal 
tubule leading to polycystic kidney development 
(100; 101).
Not described
AQP12 Increased susceptibility to caerulein-induced 
acute pancreatitis (103)
Not described
Figure 1. Secondary and terti-
ary struc ture of aquaporins. 
Aquaporins are a family of inte-
gral membrane proteins that serve 
as channels for the movement 
of water and other small solutes 
across the lipid bilayer. (A) The 
polypeptide chain of aquaporin is 
composed of six transmembrane 
α-helices and two reentrant loops 
with asparagine-proline-alanine 
(NPA) motifs; the water channels 
AQP11 and AQP12 have a unique 
asparagine-proline-cystein (NPC) 
motif. (B) in cellular membranes, 
aquaporins assemble as a tetram-
er, with each monomer forming 
a functionally independent pore 
that allows the selective passage of 
water and/or other small solutes, 
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transgenic knockout mice lacking diff erent aquaporins (Table 
1). Th e present review focuses on advances in our knowledge of 
the physiological and pathophysiological roles of aquaporins in 
rodents and humans.
Aquaglyceroporins
Aquaglyceroporins (AQP3, AQP7, AQP9 and AQP10) encom-
pass a subfamily of aquaporins permeable not only to water, 
but also to small solutes, like glycerol (1,5,6) (Fig. 2). Glycerol 
represents an important metabolite for the control of fat accu-
mulation, as the carbon backbone of triglycerides (TG), and for 
glucose homeostasis, given that glycerol constitutes the major 
substrate for hepatic gluconeogenesis during fasting (7; 8). Cir-
culating glycerol results from lipolysis, diet-derived glycerol 
or glycerol reabsorbed in proximal tubules (6). During fasting 
hepatic glucose output embodies the main source of plasma 
glucose, and plasma glycerol becomes the major substrate for 
hepatic gluconeogenesis (9,10). In addition, glycerol constitutes 
a key metabolite for lipid accumulation since it is the carbon 
backbone of triglycerides (TG). Th us, the regulation of glycerol 
transport by aquaglyceroporins contributes to the control of fat 
accumulation and glucose homeostasis, among other biological 
functions (8,11) (Fig. 3).
AQP3: urine concentration and skin hydration
AQP3 was initially cloned from rat kidney (originally named, 
GLIP, glycerol intrinsic protein, based on its glycerol transport 
function) by two independent research groups (12; 13). Although 
extremely rare, there are cases of homozygous mutations in 
AQP3 gene in humans (14). Th ese AQP3-defi cient patients de-
Figure 2. Role of aquaglyceroporins in the human body. The main aquaglyceroporins (AQP) are schematically represented 
indicating their location and function. TG, triglycerides.
Adipose tissue
Glycerol uptake for TG synthesis and 
lipolysis-derived glycerol output (AQP7)
Skin
Skin hydration and wound 
healing (AQP3) 
Intestine
Intestinal water/glycerol absorption 
(AQP3, AQP10) and secretion of 
polypeptidic hormones (AQP10)
Skeletal muscle
Osmotic homeostasis in skeletal 
myofibers (AQP3, AQP7)
Liver
Glycerol uptake for gluconeogenesis (AQP9)
AQUAGLYCEROPORIN
Heart







Participation in insulin 
production and secretion 
(AQP7)
Adipobiology 2, 2010
Biology of aquaporins12 RevIew
veloped antibodies against a new red-blood cell group protein 
aft er blood transfusion or pregnancy, but the clinical signifi cance 
of this biological function of AQP3 has not been determined. 
Until now, most of the studies have been focused on the role 
of AQP3 in renal water absorption and skin hydration (15,16). 
In the kidney, AQP3 is expressed in the apical and basolateral 
membranes of the proximal tubules (12,13). Th is aquaglycero-
porin plays a key role in the urinary-concentrating mechanism, 
since Aqp3 deletion in transgenic mice is associated with neph-
rogenic diabetes insipidus development (15). Interestingly, it has 
been recently reported that a mouse model of type 1 diabetes 
mellitus shows a decrease in AQP3 in renal inner medulla that 
serves as a compensatory mechanism to alleviate dehydration in 
diabetes mellitus (17). In the skin, AQP3 is expressed in kerati-
nocytes of the most superfi cial layer, the stratum corneum (16). 
Mice lacking Aqp3 gene exhibit a reduced skin hydration, and 
elasticity, together with an impaired reformation of stratum cor-
neum and delayed wound healing (18,19). Interestingly, glycerol 
administration, by topical or systemic routes, has been able to 
correct each of the phenotype abnormalities in the skin of Aqp3-
defi cient mice (20). Th ese fi ndings suggest that AQP3 plays an 
important role in skin hydration contributing to glycerol trans-
port across the keratinocytes. Th is fact might provide a scientifi c 
rationale for the long-standing practice of including glycerol in 
cosmetic and skin medicinal preparations. 
AQP7: control of fat accumulation
Th e human AQP7 gene, mapped to chromosome 9p13, was 
cloned from adipose tissue in 1997 (originally named AQPap) 
(21,22). AQP7 was initially described as an adipose-specifi c 
glycerol channel, but this pore is also expressed in kidneys, tes-
tes, ovaries, heart, gastrointestinal tract, and skeletal muscle (23-
28). Th e glycerol channel AQP7 plays a pivotal role in adipose 
tissue enlargement and function as well as glucose homeostasis, 
since mice lacking Aqp7 gene have been shown to develop adult-
onset obesity and type 2 diabetes mellitus (29-31). Th e main 
reason for the adipocyte enlargement in Aqp7-defi cient mice is 
the progressive hypertrophy of fat cells, characterised by larger 
Figure 3. Coordinated regulation of adipose AQP7 and hepatic AQP9 in a fasting state. Under circumstances of negative 
energy balance, triglycerides are hydrolysed by the hormone sensitive lipase (HSL) to glycerol and free fatty acids (FFA) and 
released to the bloodstream. Glycerol is secreted from the adipose tissue through AQP7, a glycerol channel mainly expressed in 
adipocytes during late adipogenesis. The hepatic-specifi c AQP9 enables the direct fl ow of glycerol from the portal vein into the 
liver. in hepatocytes, glycerol is converted to glycerol-3-phosphate by the enzymatic activity of glycerol kinase (GK) for de novo 
synthesis of glucose. Taken together, the glycerol cascade from adipose tissue to liver is maintained by coordinated regulation 
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sized lipid droplets (30,31). In circumstances of negative energy 
balance, such as fasting or exercise, TG stored in adipocytes are 
hydrolysed to glycerol and fatty acids by the hormone-sensitive 
lipase (HSL) and released into the bloodstream (5,32). AQP7 fa-
cilitates the secretion of glycerol from adipocytes (Fig. 3). Thus, 
a defective glycerol exit results in intracellular glycerol accumu-
lation. Increased adipocyte glycerol concentrations would then 
increase TG biosynthesis, resulting in a progressive adipocyte 
hypertrophy (30). 
Insulin represses AQP7 expression in adipocytes through 
the negative insulin response elements (IRE) in the promoter 
regions of this gene (33). Insulin-resistant db/db mice states 
show an increased expression of the fat-specific AQP7 despite 
their hyperinsulinaemia (34). The increase of this aquaglyc-
eroporin in the setting of insulin resistance may be caused by 
impaired IRS-1-mediated insulin signalling in adipocytes (33; 
34). Moreover, it is remarkable that AQP7 is also expressed in 
pancreatic b cells while mice lacking the Aqp7 gene displayed re-
duced b cell mass and insulin content but elevated blood insulin 
levels (35). Therefore, AQP7 modulates insulin production and 
secretion, whereas insulin reduces AQP7 expression. This coor-
dinated regulation appears to be necessary for the maintenance 
of insulinemia and glucose homeostasis.
Only a single human case of homozygous mutation in the 
coding region of the AQP7 gene has been reported up to date 
(36). This subject was neither obese nor diabetic with the only 
apparent consequence of this mutation being an impaired glyc-
erol increase in response to exercise. Fat depot-specific differ-
ences in the gene expression of AQP7 in human obesity have 
been reported with an overexpression of AQP7 in omental adi-
pose tissue suggesting an increase in overall lipolytic capacity, 
and a repression of AQP7 in subcutaneous fat pointing to the 
promotion of an intracellular glycerol accumulation and a pro-
gressive adipocyte hypertrophy (37-39). 
AQP9: regulation of hepatic gluconeogenesis
AQP9 was cloned from human peripheral leukocytes, and in 
the liver, lung and spleen (40). The presence of AQP9 in the 
liver as well as its negative regulation by insulin opened up a 
new field of research regarding the role of this aquaglyceroporin 
in glucose homeostasis (34). During fasting, plasma glycerol is 
introduced into hepatocytes by the liver-specific aquaglycerop-
orin AQP9, where it is converted into glycerol-3-phosphate by 
the enzymatic activity of glycerol kinase for de novo synthesis 
of glucose (9) (Fig. 3). After feeding, plasma concentrations of 
insulin increase and this hormone inhibits the gene expression 
of Aqp7 in white adipose tissue and that of Aqp9 in liver through 
the negative insulin response elements (IRE) in the promoter 
regions of these genes. Interestingly, the insulin-resistant obese 
db/db mice exhibit increased transcript levels of the fat-specific 
Aqp7 and the liver-specific Aqp9, despite their hyperinsulinae-
mia. The increase of AQP7 and AQP9 in the setting of insulin 
resistance may be caused by impaired insulin signalling in adi-
pocytes and hepatocytes (33,34). Taken together, under physi-
ological conditions, insulin-mediated regulation of AQP7 and 
AQP9 may account for the increase or decrease of glycerol re-
lease from fat and gluconeogenesis in liver, in order to regu-
late the glucose production depending on the nutritional state. 
However, in the context of insulin resistance, the overexpression 
of AQP7 and AQP9 leads to an increase of plasma glycerol and 
hepatic glucose production associated with elevated circulating 
glycerol concentrations, a condition that further aggravates the 
prevailing hyperglycaemia. It is remarkable that obese patients 
with type 2 diabetes show a down-regulation of hepatic AQP9 
transcript levels that may reflect a reduced glycerol influx into 
hepatocytes to decrease hepatic gluconeogenesis in an attempt 
to avoid a further elevation of hyperglycaemia (39,41).
AQP10: intestinal water and glycerol absorption
AQP10 is abundantly expressed in human duodenum, jejunum 
and ileum, contributing to intestinal water absorption (42,43). 
For years a paracellular pathway between epithelial cells has 
been proposed for the transport of water in the intestine. Since 
the identification of aquaporins in the gastrointestinal tract a 
transcellular pathway has been suggested, whereby water may 
pass across the absorptive epithelia via AQP10 (42). Two dif-
ferent isoforms of AQP10 have been described to be expressed 
in human small intestine: AQP10v and AQP10 (44). AQP10v is 
mainly expressed in the capillary endothelial cells of the small 
intestinal villi being possibly involved in the transport of water 
absorbed through the intestinal epithelium into blood. In this 
sense, it has been shown that AQP10v is down-regulated during 
acute cholera that may reflect a mechanism to reduce the water 
permeability of the cell membranes and thus limit the secretory 
response (45). On the other hand, AQP10 is localised in the cy-
toplasm of the gastro-entero-pancreatic (GEP) endocrine cells. 
In the small intestine, GEP cells secret several hormones, such 
as somatostatin, gastrin, glucagon, or motilin. The cellular and 
subcellular localisation of AQP10 suggests that this aquaglyc-
eroporin participates in the secretion of polypeptidic hormones 
from GEP cells. AQP10 exerts an important role in glycerol 
absorption in the small intestine, due to the fact that Western 
societies are used to consuming high-fat diets (46). Despite the 
contribution of AQP10 to intestinal water and glycerol transport 
in humans, Aqp10 has not been shown to be expressed in mice 
(46). The murine Aqp10 gene has multiple structure defects lead-
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ing to the production of non-functional proteins. Nevertheless, 
other aquaporins, such as AQP1, AQP3, AQP4 and AQP7 might 
compensate the lack of Aqp10 in the murine intestine. 
Aquaporins
Aquaporins are widely expressed in tissues implicated in high 
rates of active fl uid transport. Th ese water channels play impor-
tant functions in renal water absorption, lacrimation and aque-
ous dynamics in the eye, cerebrospinal fl uid secretion, and gen-
eration of pulmonary secretions, among others (Fig. 4).
AQP0: the optical function
AQP0 is the major intrinsic protein (original name MIP26) 
of lens fi ber cells (47). Th e lens contains a uniquely high pro-
tein concentration and low water content to maintain an el-
evated refractive index for transparency. Because of its low 
water permeability (48), AQP0 facilitates water removal from 
fi ber cells and it has been shown that heterozygous loss of this 
MIP is enough to compromise lens transparency (49). In fact, 
homozygous mutations in the AQP0 gene are associated with 
hereditary cataracts in mice and humans, suggesting that this 
water channel is required for optimal crystalline lens trans-
parency and homeostasis (49-51). Th e proposed mechanisms 
for the onset of congenital cataracts include loss of AQP0-
facilitated fi ber–fi ber adherence and impaired fi ber cell dehy-
dration (52). 
Figure 4. Role of aquaporins in the human body. The main aquaporins (AQP) are schematically represented indicating their 
location and function. 
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AQP1: the fi rst aquaporin
Th e identity of aquaporins remained unknown until the dis-
covery of a protein associated to the red cell Rh blood group 
antigens, the AQP1 (originally named CHIP28, channel-like in-
tegral protein of 28 kDa) (4,53). AQP1 was described as a water-
permeable membrane protein of red blood cells, contributing to 
the Colton blood group antigen, a minor blood group determi-
nant (54). Th e presence of AQP1 in vascular endothelium and its 
strong expression in proliferating microvessels of human and rat 
malignant tumours suggested a possible role of this water chan-
nel in angiogenesis (55). AQP1 contributes to endothelial cell 
migration, which is a key process in angiogenesis. In addition, 
AQP1 participates in NO-dependent relaxation by facilitating 
NO effl  ux from endothelial cells and NO infl ux into vascular 
smooth muscle cells (56). Th e impaired angiogenesis and en-
dothelial-dependent vasodilation in Aqp1 transgenic knockout 
mice further confi rm these vascular actions of AQP1 (55,56).
Th e high expression of AQP1 at the apical and basolateral 
membranes of the proximal tubules suggested an essential role 
in the renal urine-concentrating mechanism (57,58). Transgenic 
knockout mice lacking the Aqp1 gene had increased urine out-
put (polyuria) and decreased urine-concentrating ability (59). 
Aft er water deprivation for 36 h, Aqp1-defi cient mice became 
profoundly dehydrated due to their urine-concentrating defect, 
which further confi rmed that AQP1 is required for the forma-
tion of concentrated urine. Humans with a homozygous mu-
tation in the AQP1 gene were not polyuric, presenting normal 
glomerular fi ltration rates, free water clearance, or lithium clear-
ance (indices of proximal tubule function) (60). However, it was 
observed in a controlled clinical study that AQP1-null subjects 
were unable to concentrate urine aft er 24 h of thirsting. Th us, 
AQP1-null individuals are at risk for life-threatening clinical 
problems if they become dehydrated due to renal illness or en-
vironmental causes.
AQP2: vasopressin-inducible aquaporin
AQP2 was cloned from the apical membrane of kidney-collect-
ing tubules (originally named WCH-CD, collecting duct wa-
ter channel protein) (61). Renal water reabsorption and urine 
concentration is an important mechanism to maintain constant 
plasma osmolarity of the body fl uid compartments. In the kid-
ney, AQP2 traffi  cking mediates water transport across the api-
cal cell membrane in principal cells of the collecting ducts. Th e 
anti-diuretic hormone vasopressin stimulates its receptors on 
the principal cells in the collecting ducts of nephron, triggering 
an increase in cAMP that results in the up-regulation of AQP2, 
rendering the cell permeable to water and, hence, favouring 
water reabsorption and urine concentration (62-64). In neph-
rogenic diabetes insipidus, the kidney fails to concentrate urine 
in response to vasopressin. In this sense, autosomal recessive 
mutations in the AQP2 human gene has been shown to cause 
nephrogenic diabetes insipidus (65). Th us, an abnormal up- or 
down-regulation of the AQP2 water channels in the principal 
cells seems to be an important pathophysiological factor in the 
development of concentrating and diluting defects in progres-
sive renal disease. In this sense, patients with moderately severe 
chronic kidney disease have a reduced renal concentrating and 
diluting capacity compared to patients with milder chronic kid-
ney disease as well as healthy control subjects. Th ese phenomena 
can be attributed, at least partly, to an abnormally decreased re-
sponse in the vasopressin-cAMP-AQP2 axis (63).
AQP4: brain function
Th e cloning of AQP4 cDNA from rat brain and lungs (with the 
original name of the protein being MIWC, mercurial-insensi-
tive water channel) was reported by two independent groups 
(66,67). AQP4 participates in diff erent physiological processes, 
including the urinary concentrating mechanism or the resolu-
tion of alveolar oedema (67). Nonetheless, AQP4 constitutes the 
predominant water channel in mammalian brain and most of 
the studies as regards AQP4 have focused on its role in this or-
gan (3; 68). Th e brain is composed by two main cell types: neu-
rones, which process and transmit information, and glial cells, 
which maintain the homeostasis of neurones. AQP4 is mainly 
expressed in glial cells (66). In the blood-brain barrier, AQP4 is 
present in the astrocyte projections around blood vessels and, 
at a lower level, in endothelial cells. AQP4 is further expressed 
at sites of ependymal cells in contact with the brain-cerebros-
pinal fl uid barrier. Th is expression pattern indicates that AQP4 
is involved in water homeostasis in the brain (69). Phenotype 
analysis of transgenic mice lacking Aqp4 gene has provided 
evidence of other roles of this aquaporin, such as the involve-
ment in brain oedema, in glial cell migration and in neuronal 
signal transduction (68). In particular, AQP4 facilitates clini-
cally important water movement into and out of the brain in the 
development and resolution of brain oedema and modulation 
of AQP4 expression or function is also predicted to modulate 
glial scar formation, which may be of clinical utility in traumatic 
injury, tumour and infection. Moreover, recent data suggest an 
increase in extracellular space volume in AQP4 defi ciency and 
an impaired K+ reuptake by AQP4-null astrocytes, which may be 
related to functional signifi cant AQP4-K+ channel interactions 
(69). It is interesting to note the fi rst case report of a patient with 
anti-AQP4 antibody who presented with recurrent hypersomnia 
as the main symptom, symmetrical hypothalamic lesions as well 
as a reduced orexin (hypocretin) level in the cerebrospinal fl uid 
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(70). Based on the properties of AQP4 in the brain, it has been 
proposed that regulation of AQP4 might be useful as a novel 
therapeutic strategy against hydrocephalus, traumatic brain in-
jury, epilepsy and stroke (3; 68). 
AQP5: saliva, tears and pulmonary secretions
AQP5 was cloned from rat lacrimal, salivary and respiratory 
tissues (71). AQP5 is implicated in the generation of saliva and 
tears. In fact, Aqp5 deletion in mice is associated with produc-
tion of low volume hypertonic viscous saliva (72). The pres-
ence of AQP5 in the acinar cells of lacrimal and salivary glands 
opened up the hypothesis that abnormalities in AQP5 expres-
sion in these secretor glands may occur in patients with pri-
mary Sjögren’s syndrome (PSS), an autoimmune disorder that 
is clinically characterised by dry eyes and mouth (73,74). This 
hypothesis remains unclear, since other authors discarded a ma-
jor role of AQP5 in the pathogenesis of PSS because they did not 
observe changes in the distribution and expression of AQP5 in 
patients suffering this disease (75). 
The importance of AQP5 to human disease may also include 
disorders in lung and airways (76). AQP5 is expressed in alveo-
lar type I and II cells as well as in the tracheal and bronchial 
epithelium of mice conferring high osmotic water permeability 
(71,77). Aqp5-null mice present bronchial hyperactivity after 
cholinergic stimulation, suggesting a physiological role of AQP5 
in modulating airway responsiveness and bronchoconstriction 
(77). Interestingly, some forms of human asthma have been 
linked to chromosome 12q close to the site where the AQP5 gene 
is located. Nevertheless, a role for AQP5 in human asthma has 
not yet been studied. Moreover, AQP5 has been also implicated 
in the proliferation and metastasis of lung cancer and its expres-
sion is highly increased in human lung adenocarcinomas (78).
AQP6: acid-base homeostasis
AQP6 has been cloned from the rat (WCH3) and human 
(hKID) kidney (79). In glomeruli, AQP6 is present in the mem-
brane vesicles within the cell bodies of podocytes, suggesting a 
possible role in glomerular filtration (80). AQP6 also resides in 
the intracellular vesicles of acid-secreting α-intercalated cells of 
the collecting duct of the kidney (80,81). In these vesicles AQP6 
colocalizes with the H+-ATPase, a protein that participates in 
the secretion of acid into the urine. Intercalated cells respond 
to acid-basic changes by translocating H+-ATPase from the cy-
toplasmic vacuoles to the apical plasma membrane, where this 
ion pump secretes proton from the cells by using ATP supplied 
by the numerous mitochondria (81). Interestingly, AQP6 per-
meates anionic ions, especially nitrate, as well as water (82). In 
this regard, AQP6 expression in collecting ducts increases in 
response to chronic metabolic alkalosis or increased water in-
take (83). Thus, AQP6 probably participates in the maintenance 
of acid-base homeostasis through the regulation of proton ex-
cretion by increasing the transport of water through the apical 
plasma membrane. 
AQP8: digestive fluid secretion and reproductive function
Three independent research groups reported the cloning and 
functional analysis of AQP8 in 1997 (84-86). AQP8 transcript 
expression has been found in different organs of the digestive 
system, such as salivary glands, pancreas, liver, gallbladder, 
small intestine and colon. Several possible functions have been 
proposed for AQP8, including secretion of saliva and pancre-
atic fluid, as well as intestinal fluid absorption/secretion (87). 
The presence of AQP8 in the hepatobiliary system is important 
for bile formation and secretion with defective expression of 
hepatocyte AQP8 contributing to bile secretory dysfunction in 
cholestasis (88; 89). Bile formation is initiated by hepatocytes 
and is modified by secretory and absorptive processes in the epi-
thelial cells of the intrahepatic ducts and gallbladder. In spite of 
its intracellular location in hepatocytes, under basal conditions, 
AQP8 is inserted into the plasma membrane to facilitate the 
transport of water together with AQP9 in response to hormonal 
stimuli, such as glucagon (90). The hormone glucagon stimu-
lates hepatocyte bile formation and it induces AQP8 vesicle 
trafficking to the hepatocyte canalicular domain (91). Thus, glu-
cagon increases the AQP8-mediated osmotic membrane water 
permeability, facilitating the movement of a process likely to be 
relevant to glucagon-induced bile secretion. In the gallbladder, 
AQP8 and AQP1 also contribute to the water absorption and 
secretion required for bile formation and secretion (92). 
The discovery of AQP8 in testes and ovaries has provided 
information for better understanding central processes that re-
quire water movement in the biology of reproduction (24; 84). In 
the male reproductive tract AQP8 is uniformly expressed in the 
Sertoli cells, primary spermatocytes and elongated spermatids 
of the seminiferous tubules (84; 93). This ontogeny and distribu-
tion indicate that AQP8 is involved in the secretion of fluid to 
form the lumen of seminiferous tubules occurring during testes 
development and the fluid movements during spermatogenesis 
and sperm concentration and maturation. On the other hand, 
several physiological processes need water movement in the 
female reproductive tract. Oocytogenesis or conversion of the 
oocyte into the mature ovum requires the formation and expan-
sion of the fluid-filled antrum surrounding the cell. The water 
influx into ovarian antral follicles is mediated by AQP7, 8 and 9 
expressed in the granulosa cells (24). Besides its participation in 
the gametogenesis, AQP8 is also involved in early stages of preg-
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nancy (94). The implanting blastocyst expresses both AQP8 and 
AQP9, probably for fluid/solute transport during the embryo/
placental development. 
AQP11 and AQP12: the superaquaporins
The completion of the Human Genome project revealed two 
more aquaporin-like genes, AQP11 and AQP12 (original names 
AQPX1 and AQPX2) (95). In contrast to conventional aquapor-
ins showing two highly conserved NPA boxes (Fig. 1), AQP11 
and AQP12 have a NPA box and a unique asparagine-proline-
cystein (NPC) motif (96; 97). AQP11 and AQP12 were grouped 
as superaquaporins, since they belong to the aquaporin super-
family with very low homology to conventional aquaporins. 
AQP11 is highly expressed in rat testis while being moderate-
ly expressed in the kidney, liver and brain (98). To gain insight 
into the physiological role of AQP11, a transgenic mice lacking 
Aqp11 gene was produced by Morishita et al (99). Although 
Aap11 deletion was not lethal, most knockout mice died be-
fore weaning. The cause of death was the advanced renal failure 
due to vacuolisation and cyst formation of the proximal tubule, 
leading to polycystic kidney development. To a lesser extent, 
vacuoles were also observed in other organs (the liver and the 
small intestine). The vacuoles are mostly originated from the 
endoplasmic reticulum, suggesting that Aqp11-knockout mice 
may have intravesicular defects leading to the accumulation of 
unprocessed substances inside the vacuoles (100,101). Thus, 
AQP11 seems to play a relevant role in intravesicular homeosta-
sis, which is essential for an adequate proximal tubular function.
AQP12 is selectively expressed in the pancreas (95). The exo-
crine pancreas has the ability to secrete daily large amounts of 
fluid into the duodenum (1-2.5 litres of juice containing digestive 
enzymes in humans). The intracellular localization of AQP12 
in pancreatic acinar cells suggests a potential role of this water 
channel in the maturation and exocytosis of zymogen granules 
(102). Nevertherless, the deficiency of Aqp12 in transgenic mice 
did not affect the overall pancreatic exocrine function under 
a normal breeding environment, but Aqp12-knockout mice 
showed a more severe pathology resulting from cholecystoki-
nin-8 analog-induced pancreatitis than wild type mice (103).
Conclusion
The discovery of aquaporins and the analysis of the phenotype 
of transgenic mice lacking different aquaporins has led to sub-
stantial advances in the life and medical sciences (Table 1) (104). 
The impaired function of aquaporins has been associated with 
several human diseases, such as congenital cataracts or neph-
rogenic diabetes insipidus. These studies have provided new in-
sights into the underlying mechanisms of well-known human 
diseases, indicating that pharmacological modulation of water 
and/or glycerol transport targeting aquaporins may provide 
novel opportunities for therapeutic interventions in several hu-
man disorders. From a clinical point of view, the possibility of 
regulating the expression of aquaporins in several tissues offers 
potentially different therapeutic approaches for a number of 
diseases. In this context, the design of small-molecule modula-
tors of aquaporin expression/function may have clinical applica-
tions in the therapy of congestive heart failure and hypertension 
(AQP1 and AQP2 inhibitors), cytotoxic and vasogenic types of 
brain swelling (AQP4 modulators), obesity (AQP7 up-regula-
tors), and tumour angiogenesis (AQP1 inhibitors), among oth-
ers. Nonetheless, additional data, related to gene expression and 
protein stability are needed to better establish a firm mechanistic 
basis for the involvement of aquaporins in the ethiopathogen-
esis of these metabolic disorders. Undoubtedly, aquaporins have 
broadened our understanding of the implications of water bal-
ance as well as water/glycerol transport to mammalian patho-
physiology. Given the versatile functions of aquaporins, addi-
tional and unexpected roles of these channels are sure to emerge 
in the coming years.
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